CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2022		84,610,114
Beginning Balance at Dec. 31, 2022	$ 73,033	$ 8	$ 165,912	$ (92,887)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with an At Market Issuance Sales Agreement/stock purchase agreement, net of issuance cost (in shares)		331,351
Issuance of common stock in connection with an At Market Issuance Sales Agreement/Stock Purchase Agreement, net of issuance cost	2,376		2,376
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)		30,000
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	2		2
Stock-based compensation	726		726
Net loss	(9,102)			(9,102)
Ending Balance (in shares) at Mar. 31, 2023		84,971,465
Ending Balance at Mar. 31, 2023	67,035	$ 8	169,016	(101,989)
Beginning Balance (in shares) at Dec. 31, 2022		84,610,114
Beginning Balance at Dec. 31, 2022	73,033	$ 8	165,912	(92,887)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(27,042)
Ending Balance (in shares) at Sep. 30, 2023		87,642,244
Ending Balance at Sep. 30, 2023	65,756	$ 9	185,676	(119,929)
Beginning Balance (in shares) at Mar. 31, 2023		84,971,465
Beginning Balance at Mar. 31, 2023	67,035	$ 8	169,016	(101,989)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with an At Market Issuance Sales Agreement/stock purchase agreement, net of issuance cost (in shares)		875,772
Issuance of common stock in connection with an At Market Issuance Sales Agreement/Stock Purchase Agreement, net of issuance cost	8,177	$ 1	8,176
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)		146,223
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	1		1
Exercise of stock warrants (in shares)		100
Issuance of common stock upon exercise of stock warrants, net of issuance cost	1		1
Stock-based compensation	924		924
Net loss	(9,448)			(9,448)
Ending Balance (in shares) at Jun. 30, 2023		85,993,560
Ending Balance at Jun. 30, 2023	66,690	$ 9	178,118	(111,437)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with an At Market Issuance Sales Agreement/stock purchase agreement, net of issuance cost (in shares)		1,269,441
Issuance of common stock in connection with an At Market Issuance Sales Agreement/Stock Purchase Agreement, net of issuance cost	6,331		6,331
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)		379,243
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	112		112
Stock-based compensation	1,115		1,115
Net loss	(8,492)			(8,492)
Ending Balance (in shares) at Sep. 30, 2023		87,642,244
Ending Balance at Sep. 30, 2023	$ 65,756	$ 9	185,676	(119,929)
Beginning Balance (in shares) at Dec. 31, 2023	88,869,463	88,869,463
Beginning Balance at Dec. 31, 2023	$ 59,800	$ 9	189,454	(129,663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with an At Market Issuance Sales Agreement/stock purchase agreement, net of issuance cost (in shares)		2,853,266
Issuance of common stock in connection with an At Market Issuance Sales Agreement/Stock Purchase Agreement, net of issuance cost	8,746		8,746
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)		551,436
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	28		28
Stock-based compensation	1,247		1,247
Net loss	(9,886)			(9,886)
Ending Balance (in shares) at Mar. 31, 2024		92,274,165
Ending Balance at Mar. 31, 2024	$ 59,935	$ 9	199,475	(139,549)
Beginning Balance (in shares) at Dec. 31, 2023	88,869,463	88,869,463
Beginning Balance at Dec. 31, 2023	$ 59,800	$ 9	189,454	(129,663)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	$ (33,253)
Ending Balance (in shares) at Sep. 30, 2024	111,338,789	111,338,789
Ending Balance at Sep. 30, 2024	$ 55,999	$ 11	218,904	(162,916)
Beginning Balance (in shares) at Mar. 31, 2024		92,274,165
Beginning Balance at Mar. 31, 2024	59,935	$ 9	199,475	(139,549)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock in connection with an At Market Issuance Sales Agreement/stock purchase agreement, net of issuance cost (in shares)		1,043,053
Issuance of common stock in connection with an At Market Issuance Sales Agreement/Stock Purchase Agreement, net of issuance cost	2,074		2,074
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)		1,585,405
Issuance of common stock upon exercise of stock options and vesting of restricted stock units	68		68
Exercise of stock warrants (in shares)		13,075,664
Issuance of common stock upon exercise of stock warrants, net of issuance cost	13,628	$ 2	13,626
Stock-based compensation	1,941		1,941
Net loss	(12,517)			(12,517)
Ending Balance (in shares) at Jun. 30, 2024		107,978,287
Ending Balance at Jun. 30, 2024	65,129	$ 11	217,184	(152,066)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exchange of stock warrants for shares of common stock (in shares)		3,073,200
Issuance of common stock upon exercise of stock options and vesting of restricted stock units (in shares)		287,302
Stock-based compensation	1,720		1,720
Net loss	$ (10,850)			(10,850)
Ending Balance (in shares) at Sep. 30, 2024	111,338,789	111,338,789
Ending Balance at Sep. 30, 2024	$ 55,999	$ 11	$ 218,904	$ (162,916)